Novel therapies in multiple myelomaSINGHAL, Seema; MEHTA, Jayesh.International journal of hematology. 2003, Vol 77, Num 3, pp 226-231, issn 0925-5710, 6 p.Article

How I treat elderly patients with myelomaMEHTA, Jayesh; CAVO, Michele; SINGHAL, Seema et al.Blood. 2010, Vol 116, Num 13, pp 2215-2223, issn 0006-4971, 9 p.Article

Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001)SAFDAR, Amar; SINGHAL, Seema; MEHTA, Jayesh et al.Cancer. 2004, Vol 100, Num 11, pp 2456-2461, issn 0008-543X, 6 p.Article

Recent developments and future directions in the treatment of multiple MyelomaPICHARDO, Diely; SINGHAL, Seema; MEHTA, Jayesh et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 4, pp 497-511, issn 1084-9785, 15 p.Article

Hyperviscosity syndrome in plasma cell dyscrasiasMEHTA, Jayesh; SINGHAL, Seema.Seminars in thrombosis and hemostasis. 2003, Vol 29, Num 5, pp 467-471, issn 0094-6176, 5 p.Article

Acyclovir to Prevent Reactivation of Varicella Zoster Virus (Herpes Zoster) in Multiple Myeloma Patients Receiving Bortezomib TherapyVICKREY, Eric; ALLEN, Sharon; MEHTA, Jayesh et al.Cancer. 2009, Vol 115, Num 1, pp 229-232, issn 0008-543X, 4 p.Article

Brain repair by hematopoietic growth factors in a rat model of strokeZHAO, Li-Ru; SINGHAL, Seema; DUAN, Wei-Ming et al.Stroke (1970). 2007, Vol 38, Num 9, pp 2584-2591, issn 0039-2499, 8 p.Article

The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemiaPOWLES, Ray; SIROHI, Bhawna; TRELEAVEN, Jennifer et al.Blood. 2002, Vol 100, Num 5, pp 1641-1647, issn 0006-4971, 7 p.Article

Regression of Cardiac Amyloid After Autologous Stem-cell TransplantationBLAIR, John E. A; ZEIGLER, Sanford M; MEHTA, Jayesh et al.The Journal of heart and lung transplantation. 2009, Vol 28, Num 7, pp 746-748, issn 1053-2498, 3 p.Article

A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedemaHORN, Keren B; HORN, Meyer A; SWAN, James et al.Journal of the American Academy of Dermatology. 2004, Vol 51, Num 2, pp S120-S123, issn 0190-9622, SUPArticle

First thalidomide clinical trial in multiple myeloma : a decade laterVAN RHEE, Frits; DHODAPKAR, Madhav; CROWLEY, John et al.Blood. 2008, Vol 112, Num 4, pp 1035-1038, issn 0006-4971, 4 p.Article

Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myelomaGRUGAN, Katharine D; CHUNGUANG MA; SINGHAL, Seema et al.Journal of steroid biochemistry and molecular biology. 2008, Vol 110, Num 3-5, pp 244-254, issn 0960-0760, 11 p.Article

The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratiosSINGHAL, Seema; VICKREY, Eric; KRISHNAMURTHY, Jairam et al.Blood. 2009, Vol 114, Num 1, pp 38-39, issn 0006-4971, 2 p.Article

Long-term outcome results of the first tandem autotransplant trial for multiple myelomaBARLOGIE, Bart; TRICOT, Guido J; HOERING, Antje et al.British journal of haematology. 2006, Vol 135, Num 2, pp 158-164, issn 0007-1048, 7 p.Article

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cellsEVENS, Andrew M; LECANE, Philip; MAGDA, Darren et al.Blood. 2005, Vol 105, Num 3, pp 1265-1273, issn 0006-4971, 9 p.Article

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaRICHARDSON, Paul Gerard; BARLOGIE, Bart; SCHENKEIN, David et al.Blood. 2005, Vol 106, Num 9, pp 2977-2981, issn 0006-4971, 5 p.Article

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapyMCBRAYER, Samuel K; CHENG, Javelin C; SINGHAL, Seema et al.Blood. 2012, Vol 119, Num 20, pp 4686-4697, issn 0006-4971, 12 p.Article

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWINTER, Jane N; INWARDS, David J; MICALLEF, Ivana et al.Journal of clinical oncology. 2009, Vol 27, Num 10, pp 1653-1659, issn 0732-183X, 7 p.Article

A phase 2 study of bortezomib in relapsed, refractory myelomaRICHARDSON, Paul G; BARLOGIE, Bart; SIEGEL, David et al.The New England journal of medicine. 2003, Vol 348, Num 26, pp 2609-2617, issn 0028-4793, 9 p.Article

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphomaGENTZLER, Ryan D; EVENS, Andrew M; SINGHAL, Seema et al.British journal of haematology. 2014, Vol 165, Num 6, pp 793-800, issn 0007-1048, 8 p.Article

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myelomaZONDER, Jeffrey A; MOHRBACHER, Ann F; SINGHAL, Seema et al.Blood. 2012, Vol 120, Num 3, pp 552-559, issn 0006-4971, 8 p.Article

Instability of Immunophenotype in Plasma Cell MyelomaWENQING CAO; GOOLSBY, Charles L; NELSON, Beverly P et al.American journal of clinical pathology. 2008, Vol 129, Num 6, pp 926-933, issn 0002-9173, 8 p.Article

Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in ratsZHAO, Li-Ru; BERRA, Hector H; DUAN, Wei-Ming et al.Stroke (1970). 2007, Vol 38, Num 10, pp 2804-2811, issn 0039-2499, 8 p.Article

Hematopoietic growth factors pass through the blood-brain barrier in intact ratsZHAO, Li-Ru; NAVALITLOHA, Yot; SINGHAL, Seema et al.Experimental neurology (Print). 2007, Vol 204, Num 2, pp 569-573, issn 0014-4886, 5 p.Article

Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaBERENSON, James R; JAGANNATH, Sundar; SINGHAL, Seema et al.Cancer. 2005, Vol 104, Num 10, pp 2141-2148, issn 0008-543X, 8 p.Article